Libby Black

1.6k total citations
52 papers, 1.2k citations indexed

About

Libby Black is a scholar working on Pulmonary and Respiratory Medicine, Urology and Surgery. According to data from OpenAlex, Libby Black has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 14 papers in Urology and 11 papers in Surgery. Recurrent topics in Libby Black's work include Prostate Cancer Diagnosis and Treatment (21 papers), Urinary Bladder and Prostate Research (13 papers) and Prostate Cancer Treatment and Research (9 papers). Libby Black is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (21 papers), Urinary Bladder and Prostate Research (13 papers) and Prostate Cancer Treatment and Research (9 papers). Libby Black collaborates with scholars based in United States, Netherlands and United Kingdom. Libby Black's co-authors include Claus G. Roehrborn, Michael Eaddy, Michael E. Stokes, Michael J. Naslund, Paul Fishman, Roger S. Rittmaster, Ágnes Benedict, Indrani Nandy, Blair Egerdie and Neil Fleshner and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and American Journal of Obstetrics and Gynecology.

In The Last Decade

Libby Black

49 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Libby Black United States 19 586 338 198 182 177 52 1.2k
Katrine L. Wallace United States 13 224 0.4× 127 0.4× 332 1.7× 275 1.5× 328 1.9× 29 1.2k
Michael Herdman Spain 14 328 0.6× 67 0.2× 145 0.7× 88 0.5× 57 0.3× 38 1.4k
Mike Kirby United Kingdom 16 202 0.3× 446 1.3× 101 0.5× 235 1.3× 507 2.9× 55 1.1k
Richard J Fantus United States 20 321 0.5× 232 0.7× 450 2.3× 52 0.3× 48 0.3× 105 1.2k
Martin Marszalek Austria 22 845 1.4× 839 2.5× 420 2.1× 483 2.7× 409 2.3× 56 2.0k
Sam Colman United States 18 164 0.3× 57 0.2× 96 0.5× 72 0.4× 43 0.2× 39 1.0k
Tong-Zu Liu China 16 323 0.6× 125 0.4× 165 0.8× 90 0.5× 24 0.1× 40 947
Stephen P. Motsko United States 11 71 0.1× 154 0.5× 98 0.5× 154 0.8× 75 0.4× 23 637
Mohamed Hussein Egypt 14 67 0.1× 294 0.9× 144 0.7× 287 1.6× 33 0.2× 55 968
Barnabie Agatep United States 6 125 0.2× 680 2.0× 145 0.7× 581 3.2× 31 0.2× 22 1.2k

Countries citing papers authored by Libby Black

Since Specialization
Citations

This map shows the geographic impact of Libby Black's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libby Black with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libby Black more than expected).

Fields of papers citing papers by Libby Black

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Libby Black. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libby Black. The network helps show where Libby Black may publish in the future.

Co-authorship network of co-authors of Libby Black

This figure shows the co-authorship network connecting the top 25 collaborators of Libby Black. A scholar is included among the top collaborators of Libby Black based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Libby Black. Libby Black is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berkowitz, Richard, Alexander P. Sah, Randall J. Mack, et al.. (2021). Safety and Efficacy of Perioperative Intravenous Meloxicam for Moderate-to-Severe Pain Management in Total Knee Arthroplasty: A Randomized Clinical Trial. Pain Medicine. 22(6). 1261–1271. 8 indexed citations
2.
Carter, John A., Libby Black, Dolly Sharma, Tarun Bhagnani, & Jonathan S. Jahr. (2020). Efficacy of non-opioid analgesics to control postoperative pain: a network meta-analysis. BMC Anesthesiology. 20(1). 272–272. 12 indexed citations
4.
Kuzniewicz, Michael W., et al.. (2017). Outcomes of Admissions for Preterm Labor. American Journal of Perinatology Reports. 7(2). e116–e123. 3 indexed citations
5.
Black, Libby, et al.. (2014). Incremental Hospital Costs Associated With Comorbidities Of Prematurity. Value in Health. 17(3). A158–A158. 8 indexed citations
6.
Selli, Cesare, Anders Bjartell, Javier Burgos, et al.. (2014). Burden of Illness in Prostate Cancer Patients with a Low-to-Moderate Risk of Progression: A One-Year, Pan-European Observational Study. SHILAP Revista de lepidopterología. 2014. 1–8. 17 indexed citations
7.
Fleshner, Neil, M. Scott Lucia, Blair Egerdie, et al.. (2012). Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial. The Lancet. 379(9821). 1103–1111. 134 indexed citations
8.
Chirila, Costel, Stephanie Earnshaw, & Libby Black. (2012). Economic Analysis: Randomized, Placebo-Controlled Clinical Trial of Dutasteride in Men at High Risk for Prostate Cancer. Journal of Cancer Science & Therapy. 1(S3).
10.
11.
Kattan, Michael W., Stephanie Earnshaw, Cheryl McDade, Libby Black, & Gerald L. Andriole. (2011). Cost Effectiveness of Chemoprevention for Prostate Cancer with Dutasteride in a High-Risk Population Based on Results from the REDUCE Clinical Trial. Applied Health Economics and Health Policy. 9(5). 305–315. 6 indexed citations
12.
Crawford, E. David, et al.. (2010). A retrospective analysis illustrating the substantial clinical and economic burden of prostate cancer. Prostate Cancer and Prostatic Diseases. 13(2). 162–167. 47 indexed citations
13.
Stokes, Michael E., Libby Black, Ágnes Benedict, Claus G. Roehrborn, & Peter C. Albertsen. (2010). Long-term medical-care costs related to prostate cancer: estimates from linked SEER-Medicare data. Prostate Cancer and Prostatic Diseases. 13(3). 278–284. 26 indexed citations
14.
Black, Libby, Alyson Grove, & Betsy Morrill. (2009). The psychometric validation of a US English satisfaction measure for patients with benign prostatic hyperplasia and lower urinary tract symptoms. Health and Quality of Life Outcomes. 7(1). 55–55. 17 indexed citations
15.
Fourcade, R., Ágnes Benedict, Libby Black, et al.. (2009). Treatment costs of prostate cancer in the first year after diagnosis: a short‐term cost of illness study for France, Germany, Italy, Spain and the UK. British Journal of Urology. 105(1). 49–56. 53 indexed citations
16.
Roehrborn, Claus G., Peter C. Albertsen, Michael E. Stokes, Libby Black, & Ágnes Benedict. (2009). First-year costs of treating prostate cancer: estimates from SEER-Medicare data. Prostate Cancer and Prostatic Diseases. 12(4). 355–360. 24 indexed citations
17.
Han, Euna, Libby Black, & John P. Lavelle. (2007). Incontinence Related to Management of Benign Prostatic Hypertrophy. ˜The œAmerican journal of geriatric pharmacotherapy. 5(4). 324–334. 14 indexed citations
18.
Black, Libby, M. Chris Runken, Michael Eaddy, & Manan Shah. (2007). Chronic disease prevalence and burden in elderly men: an analysis of Medicare medical claims data.. PubMed. 33(4). 68–78. 1 indexed citations
19.
Jaime, J., et al.. (2000). The Migraine ACE Model: Evaluating the Impact on Time Lost and Medical Resource Use. Headache The Journal of Head and Face Pain. 40(4). 282–291. 16 indexed citations
20.
Fishman, Paul & Libby Black. (1999). Indirect Costs of Migraine in A Managed Care Population. Cephalalgia. 19(1). 50–57. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026